Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244694 · ClinicalTrials.gov registry record · Early Phase 1
Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT05244694 is a Early Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 28 participants.
The verdict
NCT05244694, a Early Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this project is to determine if hyperinsulinemia attenuates sympathetic nervous system-mediated vasoconstriction in the human leg.
Interventions
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2021-06-25 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05244694
The ClinicalTrials.gov registry entry for NCT05244694 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT05244694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05244694 about?
NCT05244694 is a clinical study titled "Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction". The purpose of this project is to determine if hyperinsulinemia attenuates sympathetic nervous system-mediated vasoconstriction in the human leg.
What is the current status of trial NCT05244694?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2020-08-06. Estimated completion is 2021-06-25.
What interventions are being tested in trial NCT05244694?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT05244694?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.